Retrobulbar irradiation for Graves' ophthalmopathy is considered as a safe treatment and has recently been recommended as the initial treatment for patients with moderately severe eye problems. However, calculations using risk factors presently known reveal a theoretical risk of radiation-induced cancer of 1.2%. Therefore, the authors suggest that this treatment should be reserved for the elderly patient, for example above the age of 40-50 years.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0167-8140(95)01670-8 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!